Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
about
Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.Fulminant hepatic failure due to disseminated adenovirus infection in a patient with chronic lymphocytic leukemia.Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamstersHow I treat adenovirus in hematopoietic stem cell transplant recipientsMolecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients.European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).Use of cidofovir in pediatric patients with adenovirus infection.Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods.Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compoundClinical characteristics and outcomes of adenovirus infection of the urinary tract after renal transplantation.Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children.Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.Ganciclovir ophthalmic gel treatment shortens the recovery time and prevents complications in the adenoviral eye infection.Allograft adenovirus nephritis.Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients.Adenovirus tubulointerstitial nephritis presenting as a renal allograft space occupying lesion.Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation.Effect of 6-azacytidine on the course of experimental adenoviral infection in newborn Syrian hamsters.
P2860
Q34165176-0C77AD15-25E7-42BB-82A3-8B4023621DE3Q34597872-160806CF-DD8F-49DE-A8F8-289D855DF0F9Q34681072-B66C4280-3BEA-47D4-8090-14E2B81AE34BQ35232836-C4CDCEB2-C06D-4497-B170-D74F8D0B71B2Q37788461-98B7682A-6062-4214-8F8F-352A5BCA0EC4Q38002109-8A76DD02-4486-488A-B4A5-221ED06D42D5Q38059255-4102B7CF-164B-493E-951D-AD975A313A99Q38847960-F19C5E6B-417E-45F5-8C13-A838251990F9Q39025523-21CB9BD0-18FC-4E6E-A3A2-10A4EF99B334Q39687396-CABCF83E-DD7C-4721-8124-138E3931B000Q40116510-D2BB6CD8-4960-47FE-BF83-183EC66C4ED0Q40603966-FA0FA814-77E9-4BC8-A51B-4C5BF69885EAQ40632749-6B8E7CE3-7697-4E41-9BBB-A59F64CE4FAAQ40661294-FBEE6A6E-8043-4516-9E59-82F8BECEF709Q42150045-3AE5A80B-4736-4F8D-B187-0630E905A9B9Q43791509-D9AFA143-1376-4F36-A338-7598842B1FA1Q45054598-E43A0677-20D5-42CA-9391-7CF357FE412EQ45096756-A4A7A3F4-6E2B-4403-B863-74367FB5FF6FQ45265773-9461912E-7C99-4941-8B33-9A57FD68C63BQ51799618-AD1C2173-6421-43AB-A2E4-C8C1813BEB19
P2860
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
@en
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
@nl
type
label
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
@en
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
@nl
prefLabel
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
@en
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.
@nl
P2093
P356
P1476
Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir
@en
P2093
P2888
P304
P356
10.1038/SJ.BMT.1700997
P407
P577
1997-12-01T00:00:00Z